Salute e Benessere
Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities
Quasar's evolution into a fully integrated Contract Development and Manufacturing Organization (CDMO) marks a transformative step, offering customers concept-to-commercialization solutions worldwide. The company is expanding its workforce by nearly 200 employees, including expert development engineers and technicians, creating new opportunities for advancement.
With this acquisition, Quasar strengthens its global presence with two FDA-registered, ISO 13485-certified facilities situated in key MedTech regions—Europe and North America—improving customer proximity and access. Galway, Ireland , now serves as an innovation hub for design & development for extrusions, braiding, balloons, and complex catheters, providing advanced support in product design, prototyping, and clinical innovation. Tecate, Mexico , adds cost-effective, high-volume manufacturing capabilities, facilitating a smoother transition from development to commercialization.
By expanding its regional reach and integrating Nordson Medical's design, development, and contract manufacturing capabilities into its global platform, Quasar can now provide a seamless, end-to-end solution for complex interventional devices, including:
The acquisition also greatly expands Quasar's cleanroom footprint, enhances deep technical expertise in extrusions, balloons, balloon catheters, braided shafts, and delivery systems, and creates more room for growth at both sites. Customers will benefit from regional access in North America and Europe , faster development, enhanced quality control, and more cost-effective manufacturing.
Quasar will collaborate closely with Nordson to ensure a seamless transition for employees, customers, and suppliers.
is a global Contract Development and Manufacturing Organization (CDMO) delivering end-to-end solutions for interventional and minimally invasive medical devices. With 11 global facilities and over 4,300 employees across Asia , North America , and Europe , Quasar specializes in catheter systems, balloon technologies, micro-EM sensors, and complex assemblies, delivering cost-effective scalability and unmatched speed to market. Headquartered in Singapore , the company provides fully integrated device solutions spanning design, prototyping, and scalable manufacturing. Quasar operates under ISO 13485:2016 and cGMP standards, serving leading medical device OEMs and innovators worldwide. For more information, visit www.quasarmedical.com
Logo - https://mma.prnewswire.com/media/2739704/Quasar_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/quasar-medical-strengthens-global-cdmo-platform-with-acquisition-of-nordson-medicals-galway-and-tecate-facilities-302543978.html